How do medical and social contexts affect telemedicine efficiency and quality? A propensity-score matching protocol in Canada’s primary care.

How do medical and social contexts affect telemedicine efficiency and quality? A propensity-score matching protocol in Canada’s primary care.

Publication date: Sep 23, 2025

Telemedicine use has risen significantly since the COVID-19 pandemic. Evidence suggests that the quality of care in telemedicine could be as good as in-person care, but this is likely context-dependent. Expert guidelines have declared the appropriate medical conditions, but often without empirical evidence that grapples with the fundamental information limitations facing telemedicine. We draw on the task-technology fit theory and empirical evidence around human communication to examine how the medical and social contexts affect the efficiency and clinical quality of primary care. We will use a population-based dataset from the Canadian province of British Columbia (BC) to inform a quasi-experimental study using propensity score matching (PSM). The treatment group will consist of telemedicine visits from April to December 2022. We will use PSM to create a control group of matched, in-person visits in the same period. We will then use cluster-robust linear regression to identify how specific medical conditions and social contexts are associated with higher rates of prescription, follow-up with primary care providers, emergency department visits and acute care admissions. We plan for the study to take place from 1 August 2025 to 1 August 2026. The Research Ethics BC has granted approval for this study (H21-02244-A006). Our findings will be shared with patients, healthcare providers and policymakers and disseminated through conference presentations and peer-reviewed publications.

Open Access PDF

Concepts Keywords
August British Columbia
Canada COVID-19
December Health policy
Expert Humans
Healthcare Primary Health Care
Primary Health Care
Propensity Score
Research Design
SARS-CoV-2
Telemedicine
Telemedicine

Semantics

Type Source Name
disease IDO quality
disease MESH COVID-19 pandemic
disease MESH emergency
disease MESH pneumonia
drug DRUGBANK Indoleacetic acid
disease IDO history
disease MESH eczema
disease MESH psoriasis
disease MESH depression
disease MESH chest pain
disease MESH complications
disease MESH anxiety
disease MESH acne
disease MESH upper respiratory infections
disease MESH infections
drug DRUGBANK Isoxaflutole
disease MESH anxiety disorder
disease MESH Privacy
drug DRUGBANK Aspartame
disease MESH morbidity
disease MESH Comorbidity
drug DRUGBANK Vildagliptin

Original Article

(Visited 9 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *